Phellopterin exhibits anti-inflammatory, anti-viral, and anti-tumor activities; it inhibits TNF-alpha-induced VCAM-1 expression by modulating Akt and PKC pathways, thereby suppressing monocyte adhesion to endothelial cells; it is used in combination with other bioactive compounds for antibacterial, anti-inflammatory, lung-clearing, cough-relieving, anti-viral, sedative, and cardioprotective effects, particularly in preventing recurrence of cor pulmonale.